Jun 24
LSBWF · LakeShore Biopharma Co., Ltd.
Market Cap
$2.76M
Shares
41.21M
Volume · Jul 6
97.5K
Avg daily vol (1 sessions)
97.5K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.01
Open$0.01
Day$0.01–0.01
Available close range$0.01–0.01
Avg vol since split · 1d98K
Short int1K · 0.0% of shares
Short vol100%
DataJul 2026–Jul 2026
Raw chart and full-history price indicators begin at the captured split on Oct 4, 2024; bars on opposite sides are not compared.
The closing range uses available history since Jul 6, 2026; less than a full year is stored.
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Limited
Momentum
Limited
Sentiment
Bearish
Fundamentals
Fair
Quant / Vol
Limited
Market backdrop
VIX 25.6 · fear
Equity put/call 0.59
Technical
price trend
Not enough data for a confident read.
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
-88% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of shares out · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Fundamentals
Revenue growth
+6%
Y/Y
Gross margin
82%
expanding
EPS growth
+87%
Y/Y
Free cash flow
$-18.6M
Balance sheet
$42.7M
net debt
Quant / Vol
risk profile
Not enough data for a confident read.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
-88% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of shares out · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Price context
position in its available closing range
Price range unavailable — no recent comparable closes.
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LSBWF
this stock
LakeShore Biopharma Co., Ltd.
|
$2.76M | — | +6.0% | — | 0.0% |
|
VRTX
Vertex Pharmaceuticals Inc
|
$138.71B | +20.7% | +46.2% | 35.2 | 1.7% |
|
MRNA
Moderna, Inc.
|
$101.48B | +762.0% | +4.3% | — | 8.1% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$93.55B | +17.2% | +20.8% | 20.0 | 2.1% |
|
CSLLY
Csl Ltd
|
$66.72B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
1
- % held
- 0.1%
- Net QoQ
- -298.7K sh
- Top holder
- BARCLAYS PLC
Held
Float
Short & Settlement
Financials
Filings
Performance
Raw-price comparisons begin at the captured split on Oct 4, 2024; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LSBWF | — | — | — | — | — |
| SPY | +3.1% | -0.8% | +8.2% | +0.6% | +10.2% |
| vs SPY | — | — | — | — | — |